1 Product identity
Ingredient risk
No flagged ingredients
4x LiQ-10 Syrup 200 mg Orange - Pineapple Flavor
BrandTishcon Corp.→Non-Nutrient/Non-Botanical Liquid 20 ingredients DSLD #45278Net contents: 16.9 fl. Oz.
Target: Adults and Children 4 years and above
DSLD entry: 2015-05-22
2 Ingredients (20)
IngredientGroupSafety
CaloriesCalories—
FatFat (unspecified)—
ProteinProtein (unspecified)—
CarbohydratesCarbohydrate—
plain SyrupSyrup (unspecified)—
purified WaterWater—
Medium Chain TriglyceridesMedium chain triglycerides (MCT)—
Soy Lecithinlecithin—
Orange flavorFlavor—
Polysorbate 80Polysorbate—
MaltodextrinMaltodextrin—
Pineapple flavorPineapple—
Propylene GlycolPropylene Glycol—
Citric AcidCitric Acid—
Ethyl VanillinEthylvanillin—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Coenzyme Q10 — Limited Evidence
⚠ May reduce warfarin efficacy
⚠ Mild GI effects
Potassium — Limited Evidence
⚠ Hyperkalemia risk
⚠ Dangerous with ACE inhibitors
Sucralose — Conditionally Safe
⚠ May affect gut microbiome
⚠ Heating may produce chlorinated compounds
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
4 Label claims
• All Other
5 Data source
DSLD ID45278
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2015-05-22
6 More from Tishcon Corp.
View Tishcon Corp. Safety Scorecard → 61 products
Active-Q 100 mgActive-Q 100 mgActive-Q 100 mgActive-Q 100 mgActive-Q 50 mgActive-Q 50 mg7 Cite this page
Vancouver
Pkhakadze G. 4x LiQ-10 Syrup 200 mg Orange - Pineapple Flavor — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://supplement.ge/products/dsld-45278/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG